MyFinsight
Home
Blog
About
Contact
Download
Download image
Accounts receivable
-$8,573K
something is missing
$2,038K
Stock-based compensation
$2,583K
Notes receivable
-$1,902K
Accrued expenses and
other liabilities
$683K
Depreciation and
amortization
$672K
Accrued interest on
long-term certificates of...
-$647K
Noncash lease expense
$217K
Bad debt expense and
other non-cash items
$195K
Income tax payable
$144K
Accounts payable
$139K
Equity in loss of
unconsolidated affiliate
-$21K
Loss on disposal of
property and equipment
-$16K
Gyre
-$89K
Gyre
$191K
Net cash (used in)
provided by operating...
$3,180K
Effect of exchange rate
changes on cash
$285K
Net cash provided by
financing activities
$21K
Canceled cashflow
$12,612K
Canceled cashflow
$2,017K
Change in fair value of
warrant liability
-$89K
Other (expense)
income, net
$29K
Gyre
Pharmaceuticals
$22,519K
Canceled cashflow
$162K
Net increase in cash
$431K
Canceled cashflow
$3,055K
Net (loss) income
-$9,858K
Inventories
$1,015K
Prepaid assets and other
current assets
$912K
Deferred income taxes,
net
-$738K
Change in fair value of
warrant liability
-$89K
Maturity of certificates
of deposit
$10,073K
Proceeds from sale of
equipment
$6K
Proceeds from the
exercise of stock options
-$2,017K
Canceled cashflow
$118K
Revenues
$22,519K
Gyre
Pharmaceuticals
-$162K
Net cash (used in)
provided by investing...
-$3,055K
Canceled cashflow
$10,079K
(loss) income from
operations
-$9,355K
Income tax expense
$621K
Canceled cashflow
$22,519K
Purchase of certificates
of deposit
$12,951K
Purchase of property and
equipment
$178K
Acquisition of intangible
assets
$5K
Total operating
expenses
$31,874K
Gyre
Pharmaceuticals
$621K
Selling and marketing
$14,136K
General and
administrative
$7,220K
Research and development
$6,738K
Transaction costs
$2,553K
Cost of revenues
$1,227K
Gyre
Pharmaceuticals
$14,136K
Gyre
$2,553K
Gyre
Pharmaceuticals
$1,227K
Back
Back
Cash Flow
source: myfinsight.com
GYRE THERAPEUTICS, INC. (GYRE)
GYRE THERAPEUTICS, INC. (GYRE)